{"abstract":"This is notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i), that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a Start-Up Exclusive Patent License to Nova Therapeutics LLC, a company having a place of business in Delaware, to practice the inventions embodied in the following patent applications:","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/05/24/2013-12375.html","cfr_references":[],"citation":"78 FR 31570","comment_url":null,"comments_close_on":"2013-06-10","correction_of":null,"corrections":[],"dates":"Only written comments or applications for a license (or both) which are received by the NIH Office of Technology Transfer on or before June 10, 2013 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2013-12375","effective_on":null,"end_page":31570,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/05/24/2013-12375.xml","html_url":"https://www.federalregister.gov/documents/2013/05/24/2013-12375/prospective-grant-of-a-start-up-exclusive-patent-license-agreement-treatment-of-graves-disease","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-12375?publication_date=2013-05-24","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-05-24/2013-12375/mods.xml","not_received_for_publication":null,"page_length":1,"page_views":{"count":104,"last_updated":"2026-06-27 10:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-05-24/pdf/2013-12375.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-12375.pdf?1369313512","publication_date":"2013-05-24","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/05/24/2013-12375.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2013-06-13T08:05:07Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":31570,"subtype":null,"title":"Prospective Grant of a Start-Up Exclusive Patent License Agreement: Treatment of Graves' Disease, Hyperthyroidism and Thyroid Cancer","toc_doc":"Treatment of Graves' Disease, Hyperthyroidism and Thyroid Cancer","toc_subject":"Start-Up Exclusive Patent License Agreements:","topics":[],"type":"Notice","volume":78}